As of Mar 12, 2025, the Hims & Hers Health stock's P/E ratio is 58.5. This results from the current EPS of $0.58 and stock price of $33.93.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 41.69 | N/A | $24.18 | $0.58 |
2023 | N/A | N/A | $8.9 | -$0.11 |
2022 | N/A | N/A | $6.41 | -$0.32 |
2021 | N/A | N/A | $6.55 | -$0.58 |
2020 | N/A | N/A | $14.6 | -$0.51 |
2019 | N/A | N/A | $9.9 | -$2.07 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 41.69 | 6.38% | $24.18 | $0.58 |
Sep 2024 | 39.19 | -84.47% | $18.42 | $0.47 |
Jun 2024 | 252.38 | N/A | $20.19 | $0.08 |
Mar 2024 | N/A | N/A | $15.47 | -$0.01 |
Dec 2023 | N/A | N/A | $8.9 | -$0.11 |
Sep 2023 | N/A | N/A | $6.29 | -$0.17 |
Jun 2023 | N/A | N/A | $9.4 | -$0.22 |
Mar 2023 | N/A | N/A | $9.92 | -$0.29 |
Dec 2022 | N/A | N/A | $6.41 | -$0.32 |
Sep 2022 | N/A | N/A | $5.58 | -$0.43 |
Jun 2022 | N/A | N/A | $4.53 | -$0.42 |
Mar 2022 | N/A | N/A | $5.33 | -$0.37 |
Dec 2021 | N/A | N/A | $6.55 | -$0.58 |
Sep 2021 | N/A | N/A | $7.54 | -$0.62 |
Jun 2021 | N/A | N/A | $10.89 | -$0.7 |
HIMS's PE ratio is above its peer stock NBIX.
Stock name | PE ratio | Market cap |
---|---|---|
NBIX Neurocrine Biosciences Inc | 31.92 | $10.82B |
HIMS Hims & Hers Health Inc | 54.84 | $7.07B |
NVAX Novavax Inc | N/A | $1.31B |
NVCR NovoCure Ltd | N/A | $2.22B |
The price to earnings ratio for HIMS stock as of Mar 12, 2025, stands at 58.5.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Mar 12, 2025), Hims & Hers Health's stock price is $33.93. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.58. Therefore, Hims & Hers Health's price to earnings ratio for today is 58.5. PE RATIO(58.5) = STOCK PRICE($33.93) / TTM EPS($0.58)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.